{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:10:07Z","timestamp":1760062207729,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ASTRA 2014-2020.4.01.16-0032"],"award-info":[{"award-number":["ASTRA 2014-2020.4.01.16-0032"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006768","name":"Taiyuan University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006768","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ejso.2019.10.039","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T18:49:41Z","timestamp":1572720581000},"page":"272-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["First Eastern European experience of isolated limb infusion for in-transit metastatic melanoma confined to the limb: Is it still an effective treatment option in the modern era?"],"prefix":"10.1016","volume":"46","author":[{"given":"J\u00fcri","family":"Teras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidde M.","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Teras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pille","family":"Pata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrus","family":"M\u00e4gi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland M.","family":"Teras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirje R\u00fc\u00fctel","family":"Boudinot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2019","series-title":"Skin cancers","author":"World Health Organization","key":"10.1016\/j.ejso.2019.10.039_bib1"},{"key":"10.1016\/j.ejso.2019.10.039_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1245\/ASO.2005.05.025","article-title":"Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy","volume":"12","author":"Pawlik","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1245\/s10434-014-4100-0","article-title":"In-transit melanoma metastases: incidence, prognosis and the role of lymphadenectomy","volume":"22","author":"Read","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib4","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1245\/s10434-016-5103-9","article-title":"Health-related quality of life for patients who have in-transit melanoma metastases treated with isolated limb perfusion","volume":"23","author":"Bagge","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib5","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1245\/s10434-008-9954-6","article-title":"Outcomes following isolated limb infusion for melanoma. A 14-year experience","volume":"15","author":"Kroon","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1634\/theoncologist.2009-0325","article-title":"Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety","volume":"15","author":"Moreno-Ramirez","year":"2010","journal-title":"The Oncologist"},{"key":"10.1016\/j.ejso.2019.10.039_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2018.09.013","article-title":"Access to innovative medicines for metastatic melanoma worldwile: melanoma World Society and European Association of Dermato-oncology survey in 34 countries","volume":"104","author":"Kandolf-Sekulovic","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2019.10.039_bib8","first-page":"188","article-title":"Isolated limb infusion with melphalan for recurrent limb melanoma: a simple alternative to isolated limb perfusion","volume":"7","author":"Thompson","year":"1994","journal-title":"Reg Canc Treat"},{"key":"10.1016\/j.ejso.2019.10.039_bib9","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1245\/s10434-019-07288-w","article-title":"Long-term oncologic outcomes following isolated limb infusion for loco-regionally metastatic melanoma: an international multicenter analysis","volume":"26","author":"Miura","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.crad.2011.07.049","article-title":"Technique and outcomes of isolated limb infusion for locally advanced malignant melanoma \u2013 a radiological perspective","volume":"66","author":"Chun","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ejso.2019.10.039_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5306\/wjco.v6.i4.57","article-title":"Isolated limb infusion chemotherapy with or without hemofiltration for recurrent limb melanoma","volume":"10","author":"Cecchini","year":"2015","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/2326-6066.CIR-17-0356","article-title":"Robust antitumor responses result from local chemotherapy and CTLA-4 blockade","volume":"2","author":"Ariyan","year":"2018","journal-title":"Canc Immunol Res"},{"key":"10.1016\/j.ejso.2019.10.039_bib13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1245\/ASO.2006.05.003","article-title":"A\u00a0phase II trial of isolated limbinfusion with melphalan and sactinomycin for regional melanoma and soft tissue sarcoma of the extremity","volume":"8","author":"Brady","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib14","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1245\/s10434-008-9988-9","article-title":"Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion","volume":"15","author":"Beasley","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib15","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1245\/s10434-012-2316-4","article-title":"Is melphalan dose adjustment according to ideal body weight useful in isolated limb infusion for melanoma?","volume":"19","author":"Huismans","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1245\/s10434-008-0288-1","article-title":"Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?","volume":"16","author":"McMahon","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolated perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST Guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2019.10.039_bib19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1245\/s10434-009-0394-8","article-title":"Major amputation for irresectable extremity melanoma after failure of isolated limb infusion","volume":"16","author":"Kroon","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.6004\/jnccn.2019.0018","article-title":"Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in Oncology","volume":"17","author":"Coit","year":"2019","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2019.10.039_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/mmt-2016-0031","article-title":"A\u00a0surgical perspective report on melanoma management","volume":"4","author":"Wernick","year":"2017","journal-title":"Melanoma Manag"},{"key":"10.1016\/j.ejso.2019.10.039_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00262-016-1952-0","article-title":"Intralesional treatment of metastatic melanoma: a review of therapeutic options","volume":"66","author":"Weide","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ejso.2019.10.039_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/107327481602300104","article-title":"Developments in intralesional therapy for metastatic melanoma","volume":"23","author":"Sloot","year":"2016","journal-title":"Cancer Control"},{"key":"10.1016\/j.ejso.2019.10.039_bib24","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1245\/s10434-017-6046-5","article-title":"Safety and efficacy of isolated limb infusion chemotherapy for advanced locoregional melanoma in elderly patients: an Australian multicentre study","volume":"24","author":"Kroon","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib25","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1245\/s10434-017-5803-9","article-title":"Isolated limb perfusion for melanoma is safe and effective in elderly patients","volume":"24","author":"Madu","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1245\/s10434-014-4072-0","article-title":"Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin d in melanoma","volume":"22","author":"Muilenburg","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ejso.2019.02.026","article-title":"Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center study","volume":"45","author":"Kroon","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jso.23553","article-title":"Isolated limb infusion with melphalan and actinomycin-D for melanoma: a systematic review","volume":"109","author":"Kroon","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.039_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/02656730701805520","article-title":"Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma","volume":"24","author":"M\u00f6ller","year":"2008","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.ejso.2019.10.039_bib30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage III melanoma with Ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2019.10.039_bib31","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant Pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2019.10.039_bib32","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant Darbafenib plus Trametinib in stage III BRAF mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2019.10.039_bib33","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant Nivolumab versus Ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2019.10.039_bib34","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.14694\/EdBook_AM.2015.35.e528","article-title":"Perfusion and infusion for melanoma intransit metastases in the era of effective systemic therapy","author":"Gr\u00fcnhagen","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejso.2019.10.039_bib35","first-page":"1053","article-title":"New does not always mean better: isolated limb perfusion still has a role in the management of in-transit melanoma metastases","volume":"30","author":"Puzanov","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ejso.2019.10.039_bib36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1245\/s10434-015-4969-2","article-title":"Australian multi-center study of isolated limb infusion for melanoma","volume":"23","author":"Kroon","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2019.10.039_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/cc2622","article-title":"The correlation between creatine kinase and myoglobin in critical ill patients with rhabdomyolysis","volume":"8","author":"Mikkelsen","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.ejso.2019.10.039_bib38","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/02656736.2017.1309082","article-title":"Myoglobin does not predict local toxicity in isolated limb perfusion","volume":"33","author":"Nystr\u00f6m Wendt","year":"2017","journal-title":"Int J Hyperth"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319309199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319309199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:31:50Z","timestamp":1760059910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319309199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0748798319309199"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.10.039","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First Eastern European experience of isolated limb infusion for in-transit metastatic melanoma confined to the limb: Is it still an effective treatment option in the modern era?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}